Survey
* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project
CYCORE: A Cyberinfrastructure to Support Comparative Effectiveness Research in Behavioral Medicine Susan K. Peterson1, Karen Basen-Engquist1, Wendy Demark-Wahnefried2, Alex Prokhorov1, Chaitan Baru3, Emilia Farcas3, Ingolf Krueger3, Doug Palmer3, Fred Raab3, Phil Rios3, Celal Ziftci3, Stephanie Barrera1, Laura Wolszon3, Kevin Patrick3 1The University of Texas MD Anderson Cancer Center, 2University of Alabama, Birmingham Comprehensive Cancer Center, 3The University of California at San Diego and the California Institute for Telecommunications and Information Technology (Calit2) Introduction Each year, roughly 1.44 million Americans are diagnosed with cancer and 560,000 die from it (1). The current annual US health care costs approximate $228 billion (2). While breakthroughs in cancer prevention and treatment have occurred, growing evidence suggests that lifestyle factors such as diet, exercise, body weight status, and continuing tobacco-use significantly impact the course of disease, and as yet are unaccounted for between and across trials (3-8). In 2009, Congress appropriated $1.1 billion via the American Recovery and Reinvestment Act to drive a national effort towards comparative effectiveness research (CER) to “encourage the development and use of clinical registries, clinical data networks, and other forms of electronic data to generate outcomes data” and to “evaluate the relative effectiveness of different health care services and treatment options”(9). The CYCORE (Cyberinfrastructure for Comparative Effectiveness Research) project is specifically designed to address each purpose. CYCORE’s primary aim is to create a prototype for a user-friendly, open-source cyberinfrastructure (CI) (see Figure 1) to support the collection, storage, visualization, analysis and sharing of health outcome data to enhance cancer-related CER. Figure 1: Cyber-infrastructure interfaces and services. The CI [1] provides interfaces to sensors, data and storage resources, and user applications; [2] provides core capabilities such as data acquisition, preservation, distribution, visualization, and algorithm execution; and [3] manages crosscutting concerns such as policy and identity management within the infrastructure. A Successful CI A successful CI has the capability to significantly improve CE research in cancer prevention and control by: Broadening the scope and quality of data that can be collected on factors that may contribute to prevention, treatment and control outcomes, both for persons with a cancer diagnosis, as well as those at increased risk for the disease; Exploiting and improving upon software and database systems utilized in other scientific domains to efficiently increase capacity for larger and more complex data sets; Enabling the pursuit of new research questions not addressable using current systems by improving the integration of patient data captured through objective monitoring (i.e., sensor capture) and/or selfreporting, and the subsequent analysis of those data; Providing decision support and patient adherence-monitoring for care providers; Funding support provided by National Institutes of Health RC2 CA148263 (S. K. Peterson, PI) Task Completion Vision Enabling patients to participate actively in their prevention and treatment regimens. The future vision for CYCORE is that it will serve clinical researchers and physicians by collecting and analyzing data from patients (through biometric and environmental sensors, patient self-reported data, medical records, etc.) as part of CE studies. In so doing, CYCORE will enhance CE research efforts by integrating capabilities for [a] data collection, assimilation, and quality assurance from existing and emerging data sources, [b] data distribution and event notification for use by researchers, clinicians, physicians, policy makers, and operators of the CI, [c] data analysis and visualization capabilities, and [d] governed service- and resource-integration to address security and privacy concerns throughout the infrastructure. Table 1: Device Usage Protocols and Rationale by Sample Rationale for Device Usage Advanced Colon Cancer Patients H&N Cancer Patients Currently Receiving Radiation Therapy Device Arm 1: Exercise Arm 2: Adherence Dehydration Risk (n=15) (n=15) Arm 3: Swallowing Exercise Adherence (n=15) To collect, encrypt, To collect, encrypt, To collect, and transmit data and transmit data encrypt, and from the from the weight transmit data from Home Health Hub accelerometer, BP, scale, the weigh scale to HR, and GPS accelerometer, BP, the CI devices to the CI and HR devices to the CI Accelerometer To monitor To monitor with HHH N/A frequency of activity frequency of activity interface (#1) To assess change To assess change in physiological in physiological Blood pressure parameters related parameters related N/A monitor to physical activity to risk of dehydration To monitor weight To monitor weight fluctuations related fluctuations to dehydration or related to Weight scale N/A inadequate food/ dehydration or fluid intake inadequate food/ fluid intake To assess change To assess change in physiological in physiological Heart rate monitor parameters related parameters related N/A to physical activity to risk of dehydration To monitor changes Global positioning in movement N/A N/A system outside of the home Carbon monoxide monitor N/A N/A To capture To capture behavior-related behavior-related data related to data about exercise adherence dehydration risks over multiple time (diet, fluid intake) points; to initiate over multiple time points; to capture Smart phone with sensor-related responses about EMA Capabilities behaviors urine color; to initiate sensorrelated behaviors; to assess pain and fatigue symptomology Smart phone with video capabilities N/A N/A N/A To capture behavior-related data about dehydration risks (diet, fluid intake) over multiple time points; to capture responses about urine color; to initiate sensorrelated behaviors; to assess pain and fatigue symptomology To capture adherence to swallowing exercises Cancer Survivors 1Year after Diagnosis, Smokers or Recent Quitters Arm 4: Smoking Cessation Adherence (n=15) N/A Specific Aims To gather requirements data to determine: [a] parameters to measure and data formats, [b] storage requirements, [c] needed manipulations, [d] output formats, and [e] userfriendly interfaces between clinicians, researchers, and patients; Requirements for CI development have been gathered from 77 stakeholders, including multidisciplinary oncological researchers and clinicians, who have informed the development of the initial prototype. The next phase of CYCORE involves the feasibility testing and evaluation (see Table 1), in a target patient population, of behavior-related cancer treatment and prevention strategies that have been hampered by well-known problems: poor patient adherence, inability to accurately measure environmental influences on health, and limited objectively-collected data regarding lifestyle behaviors. The CI will provide the interface between patients and CYCORE’s intelligent Home Health Hub (HHH) (Figures 2 and 3), to which a set of biometric and environmental sensors will provide objective capture of behavior-related data that are then relayed to a data-management system via a web-service interface. Home Health Hub Component Diagram WAN (Internet) N/A N/A CPU / Core WIFI Serial Sensor Interfaces (RS232) Cellular N/A N/A RF (Bluetooth, 802.11) Ethernet To create CI for data aggregation, integration, processing, mining, storage and retrieval; Dialup LCD / (POTS) 3 Button Console USB User Interface (3 line text/response) To build data acquisition hardware and software, including: interfaces with multi-format electronic medical records and cancer Biomedical Informatics Grid (caBIG) data, physiological sensors for at-home and unconfined use, and digitization methods for self-reported data; Figure 3: Hardware component diagram for the Calit2 Home Health Hub showing; Internet connection interfaces (blue), core computer (green), user interface (orange), and data sensor interfaces (purple). References N/A 1. To capture carbon monoxide component of expired air To capture behavior-related data related to smokingcessation adherence over multiple time points; to initiate sensor-related behaviors To develop applications to be used in conjunction with the CI, including implementation of novel brain-based device methods for data analysis; To conduct feasibility studies with the new technology, feeding results back into CI design for improvement and enhancement. 2. 3. Figure 2: CYCORE Scenario. Data from self-patient reports and body-worn sensors (interacting with the Home Health Hub), complemented by fixed sensors in the environment, can be collected and analyzed (using, for example, Brain-Based Devices) to perform comparative effectiveness studies. 4. 5. 6. 7. To capture adherence to CO monitoring protocol 8. 9. Naik AD, Petersen LA. The neglected purpose of comparative-effectiveness research. N Engl J Med 2009;360:1929-31. Garber AM, Tunis SR. Does comparative-effectiveness research threaten personalized medicine? N Engl J Med 2009;360:1925-7. Centers for Disease Control and Prevention. Accessed 3/31/2009, at http://www.cdc.gov. Allan J, Barwick TA, Cashman S, et al. Clinical prevention and population health Curriculum framework for health professions. Am J Prev Med 2004;27:471-76. Gritz ER, Dresler C, Sarna L. Smoking, the missing drug interaction in clinical trials: ignoring the obvious. Cancer Epidemiol Biomarkers Prev 2005;14:228793. Bairati I, Meyer F, Jobin E, et al. Antioxidant vitamins supplementation and mortality: a randomized trial in head and neck cancer patients. Int J Cancer 2006;119:2221-4. Chlebowski RT, Aiello E, McTiernan A. Weight loss in breast cancer patient management. J Clin Oncol 2002;20:1128-43. Holmes MD, Chen WY, Feskanich D, Kroenke CH, Colditz GA. Physical activity and survival after breast cancer diagnosis. JAMA 2005;293:2479-86. Initial national priorities for comparative effectiveness research. Committee on Comparative Effectiveness Research Prioritization, Institute of Medicine. Accessed 10/6/2010 at http://www.nap.edu/catalog/12648.html.